Pathogenesis and Therapy of Oral Carcinogenesis
We present our reprint dedicated to the study of oral squamous cell carcinoma (OSCC). Despite advances in diagnosis and treatment, OSCC remains a challenge for scientists and clinicians worldwide. This compilation of articles addresses novel biomarkers and therapeutic targets for the prevention and...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_113870 | ||
005 | 20230911 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230911s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-8430-0 | ||
020 | |a 9783036584317 | ||
020 | |a 9783036584300 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-8430-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Tarle, Marko |4 edt | |
700 | 1 | |a Lukšić, Ivica |4 edt | |
700 | 1 | |a Tarle, Marko |4 oth | |
700 | 1 | |a Lukšić, Ivica |4 oth | |
245 | 1 | 0 | |a Pathogenesis and Therapy of Oral Carcinogenesis |
260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (224 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a We present our reprint dedicated to the study of oral squamous cell carcinoma (OSCC). Despite advances in diagnosis and treatment, OSCC remains a challenge for scientists and clinicians worldwide. This compilation of articles addresses novel biomarkers and therapeutic targets for the prevention and treatment of OSCC. Articles cover topics such as the combined use of pathway inhibitors in cancer control, the role of genes and microRNAs, the interaction between smoking and HPV infection, and potential biomarkers for diagnosis and therapy. These publications provide insights into the latest research and inspire further innovation. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a oropharyngeal squamous cell carcinoma | ||
653 | |a HPV | ||
653 | |a nucleophosmin | ||
653 | |a inflammation | ||
653 | |a mast cells | ||
653 | |a MCs | ||
653 | |a oral squamous cell carcinoma | ||
653 | |a OSCC | ||
653 | |a soluble factors | ||
653 | |a CC chemokine ligand 2 | ||
653 | |a CCL2 | ||
653 | |a MCP-1 | ||
653 | |a lymph node metastases | ||
653 | |a molecular imaging | ||
653 | |a immunohistochemistry | ||
653 | |a urokinase-type plasminogen activator receptor | ||
653 | |a tissue factor | ||
653 | |a integrin αvβ6 | ||
653 | |a squamous cell carcinoma | ||
653 | |a oral cavity | ||
653 | |a biomarkers | ||
653 | |a nEGFR | ||
653 | |a immunocytochemistry | ||
653 | |a caveolin-1 | ||
653 | |a cell polarization | ||
653 | |a cholesterol | ||
653 | |a migration | ||
653 | |a E2F2 | ||
653 | |a miR-125b-5p | ||
653 | |a miR-155-3p | ||
653 | |a miR-214-5p | ||
653 | |a tumour | ||
653 | |a margin | ||
653 | |a cancer | ||
653 | |a head and neck | ||
653 | |a human papillomavirus | ||
653 | |a cigarette smoke | ||
653 | |a SOD2 | ||
653 | |a DNA damage | ||
653 | |a PEITC | ||
653 | |a Nutri-Jelly | ||
653 | |a oral cancer | ||
653 | |a tertiary chemoprevention | ||
653 | |a p53 | ||
653 | |a clinical trial | ||
653 | |a survival | ||
653 | |a quality of life | ||
653 | |a polymorphism | ||
653 | |a lysyl oxidase | ||
653 | |a human | ||
653 | |a mouse model | ||
653 | |a 4 NQO | ||
653 | |a extracellular matrix | ||
653 | |a tumor suppressor | ||
653 | |a pathogenesis | ||
653 | |a periodontitis | ||
653 | |a circulating cell-free DNA | ||
653 | |a oral disease | ||
653 | |a periodontics | ||
653 | |a tooth loss: oral cancer | ||
653 | |a trials | ||
653 | |a Wnt pathway | ||
653 | |a hedgehog pathway | ||
653 | |a β-catenin | ||
653 | |a PRI-724 | ||
653 | |a vismodegib | ||
653 | |a erlotinib | ||
653 | |a HS-173 | ||
653 | |a head and neck cancer | ||
653 | |a cancer stem cells | ||
653 | |a synergism | ||
653 | |a epidermal growth factor receptor | ||
653 | |a EGFR | ||
653 | |a prognosis | ||
653 | |a systematic review | ||
653 | |a meta-analysis | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7711 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/113870 |7 0 |z DOAB: description of the publication |